CHINA PHARMA HOLDINGS, INC. Restricted Cash and Cash Equivalents
CHINA PHARMA HOLDINGS, INC. (CPHI) had Restricted Cash and Cash Equivalents of $957.65 thousand as of 2020-12-31, per its 10-K filed 2021-03-26.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2021-03-26
- 2020-12-31: Restricted Cash and Cash Equivalents $957.65K.
- 2020-06-30: Restricted Cash and Cash Equivalents $223.00K.
- 2020-03-31: Restricted Cash and Cash Equivalents $331.04K.
- 2019-12-31: Restricted Cash and Cash Equivalents $1.18M; Restricted Cash and Cash Equivalents as first filed $109.91K.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2020-12-31 | $957.65K 10-K · filed 2021-03-26 | |
| 2020-06-30 | $223.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $331.04K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.18M 10-K · filed 2021-03-26 | $109.91K 10-K · filed 2020-03-30 |
| 2019-09-30 | $489.21K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $503.31K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $976.62K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.27M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $1.48M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.63M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.18M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $709.80K 10-K · filed 2019-03-28 | |
| 2017-09-30 | $1.38M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $2.57M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.72M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.09M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $1.47M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.25M 10-Q · filed 2016-08-11 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |